Bio-Rad Laboratories (BIO) P/B ratio

P/B ratio today
1.3×

Bio-Rad Laboratories (BIO) trades at 1.3× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 1.1×. That is 21.4% lower than the 1.4× of fiscal 2024. Figures as of 18 Nov 2026, 09:27 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio today
1.3×
P/B ratio, fiscal 2025
1.1×
Change on fiscal 2024
−21.4%
Highest on record
2.4×fiscal 2017
Lowest on record
1.1×fiscal 2023
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Bio-Rad Laboratories P/B ratio, in more detail

Today's figure is 18.2% above the fiscal 2025 year-end.

Across the 18 fiscal year-ends on record (2008–2025), the highest was 2.4× in fiscal 2017 and the lowest 1.1× in fiscal 2023. Today's P/B ratio is higher than at 17% of the 18 fiscal year-ends on record; their median is 1.7×.

History · 18 fiscal years

P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Bio-Rad Laboratories P/B ratio, year by year

Bio-Rad Laboratories (BIO) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
Today1.3×—$358.19—
20251.1× 21.4% down$302.99$273.22
20241.4× 30.8% up$328.51$232.84
20231.1× 17.2% down$322.89$299.26
20221.3× 21.9% down$420.49$322.82
20211.7× 6.2% down$755.57$453.03
20201.8× 8.4% down$582.94$327.91
20191.9× 11.1% up$370.03$190.72
20181.7× 28.6% down$232.22$133.00
20172.4× 16.8% up$238.67$97.56
20162.1× 27.7% up$182.28$87.00
20151.6× 2.0% up$138.66$84.50
20141.6× 1.6% down$120.56$74.95
20131.6× 9.4% up$123.61$75.65
20121.5× 4.8% down$105.05$70.35
20111.6× 17.6% down$96.04$61.26
20101.9× 10.7% down$103.85$54.59
20092.1× 9.6% up$96.46$45.27
20081.9×—$75.31$38.74

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

P/B ratio at health care companies of similar size

P/B ratio of Bio-Rad Laboratories and comparable companies
CompanyP/B ratio
Ensign Group ENSG4.9×
Vaxcyte PCVX3.5×
Bio-Rad Laboratories BIO1.3×
Molina Healthcare MOH2.8×
Spyre Therapeutics SYRE12.5×
Qiagen QGEN2.7×

Today's market value divided by shareholders' equity at the latest fiscal year-end. A company whose statements are in another currency than its shares is left out.

More on BIO

Bio-Rad Laboratories, figure by figure

Bio-Rad Laboratories (BIO) overview: price, valuation and scorecardAll health care companies by market value

Bio-Rad Laboratories P/B ratio: questions and answers

What is Bio-Rad Laboratories's P/B ratio?

Bio-Rad Laboratories (BIO) trades at 1.3× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 1.1×. That is 21.4% lower than the 1.4× of fiscal 2024.

Is Bio-Rad Laboratories's P/B ratio high or low compared with its own history?

Today's P/B ratio is higher than at 17% of the 18 fiscal year-ends on record; their median is 1.7×.

What are the highest and lowest P/B ratio figures on record for Bio-Rad Laboratories?

Across the 18 fiscal year-ends on record (2008–2025), the highest was 2.4× in fiscal 2017 and the lowest 1.1× in fiscal 2023.

How is Bio-Rad Laboratories's P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For Bio-Rad Laboratories it is on record here for 18 fiscal years, 2008 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bio-Rad Laboratories (BIO) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/BIO/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.